source Post navigation Optimizing Cardiovascular Outcomes in Type 2 Diabetes: Early Initiation of Dapagliflozin and Sitagliptin From a Cardiologist's Perspective – The Cureus Journal of Medical Science Now in Iowa: Blue Circle Health's type 1 diabetes care program expands to 10th state – PR Newswire